Current Edition

Regional News

FDA clears Braeburn’s long-acting Brixadi to treat opioid use disorder

As the United States’ opioid epidemic rages on, health officials are busy looking for ways to help with the response. Now, right on the heels …

Continue Reading →
Regional News

Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro

In financial distress last May, AstraZeneca spinout Entasis Therapeutics sold out to holding company Innoviva for $113 million. A year later—to the day—Innoviva’s subsidiary has scored its …

Continue Reading →
Regional News

Viatris scouts for new board chair as longtime leader Robert Coury transitions to advisory role

Viatris Chairman Robert Coury has called the shots at Mylan and its successor Viatris for many years, but now he’s getting ready to hang it …

Continue Reading →
Regional News

The clock’s ticking on Stelara: Amgen, J&J ink patent settlement

After the recent high-profile loss of exclusivity for AbbVie’s megablockbuster immunology drug Humira, industry watchers’ eyes moved to Johnson & Johnson’s Stelara as one of …

Continue Reading →
Regional News

Intercept’s latest NASH bid in jeopardy after FDA questions drug’s efficacy, safety

An industry-first FDA approval for a nonalcoholic steatohepatitis (NASH) therapy may still be a ways off. After reviewing Intercept Pharmaceuticals’ latest application for obeticholic acid …

Continue Reading →
Regional News

Does FTC attempt to block Amgen’s Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say

News of the Federal Trade Commission (FTC) lawsuit challenging Amgen’s $28 billion buyout of Horizon prompted an immediate question: Will the U.S. antitrust enforcer also attempt to …

Continue Reading →
Regional News

Regulatory tracker: Another China-made PD-1 starts FDA journey as Elevar, Hengrui target big cancer type

After a high-profile rejection for Innovent Biologics’ Tyvyt, another China-made PD-1 inhibitor is starting a bid to win an FDA approval. Elevar Therapeutics has filed …

Continue Reading →
Regional News

Allergan’s new skin-smoothing product gets FDA nod—with novel delivery mechanism

AbbVie’s aesthetics unit is growing its product catalog once again with a new FDA approval. The product, called Skinvive, nabbed an FDA nod this week and falls within …

Continue Reading →
Regional News

DeepIntent, Roku pitch ‘silver streamers’ as golden opportunity for pharma ad campaigns

DeepIntent and Roku want to challenge the idea that watching TV on streaming services is the preserve of the young. With 79% of people aged …

Continue Reading →
Regional News

ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the appointment of Nick Clare to the ELRIG board. He will chair and lead …

Continue Reading →